PR TIMES - 2025 Year in Review and 2026 Outlook

As 2025 came to a close, DLeader reflected on a year of significant progress, including its selection for Techstars Tokyo 2025 and the launch of joint research with the Mizuguchi Laboratory at Osaka University.
The article also outlined DLeader’s priorities for 2026, including expanding collaborative research, strengthening its international presence, further improving the no-code experience of KumiChem™, and deepening partnerships with pharmaceutical companies, research institutions, and other life science organizations in Japan and globally.
Building on the momentum of 2025, DLeader will continue advancing KumiChem™ as an AI-native platform for RNA drug discovery and expanding collaborations that accelerate the translation of scientific innovation into practical drug discovery workflows.